Gavin Samuels

Gavin Samuels is an accomplished executive with extensive experience in business development and strategy within the pharmaceutical and biotherapeutics sectors. Currently serving as Chief Business Officer and General Partner at CinRx Pharma, responsibilities include overseeing strategic, business, and corporate development functions. Previously, positions held include Head of Strategy & Growth Initiatives at Lonza, where innovative business models were developed for the CDMO industry, and Executive Board Member & Acting CEO at Nectin Therapeutics, focused on next-generation immunotherapy. Gavin's career at Quark Pharmaceuticals included senior roles in corporate development and investor relations, while earlier experience at Teva and Pfizer involved leading licensing strategies and negotiations across various therapeutic areas. Gavin holds degrees in Medicine, Health Economics, and an MBA from distinguished institutions.